Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
45 participants
OBSERVATIONAL
2021-05-01
2021-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture and Chinese Herbal Medicine to Improve Live Birth Rate of in Vitro Fertilization (IVFAct)
NCT04407871
Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle
NCT04935073
Effect of Traditional Chinese Medicine (TCM) on Embryo Implantation in In-vitro Fertilization (IVF) Patients
NCT01296009
Miscarriage Preventing Herbal Medicines and the Risk of Birth Defects: a Population-based Cohort Study
NCT06048276
Observing the Curative Effect of Assisted Reproduction by TCM Multi-channel Interventional Therapy
NCT02303665
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
Pregnant women who received IVF and not taken Chinesene fetal protection medicine until sampling
No interventions assigned to this group
medicine group
Pregnant women who received IVF and have taken Chinesene fetal protection medicine from the fourth week during early pregnancy
Fetal Protection Pill
A Chinese medicine used in pregnant women for fetal protection, including mainly Rehmannia glutinosa.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fetal Protection Pill
A Chinese medicine used in pregnant women for fetal protection, including mainly Rehmannia glutinosa.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* childbirth without miscarriage
* taking vitamins during pregnancy
Exclusion Criteria
* missed sampling in the fourth week of pregnancy
* not appropriate judged by the doctor
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Institute of Palnned parenthood research
UNKNOWN
Shanghai Meiji Health Science and Technology Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Enuo Liu, Dr.
Role: STUDY_CHAIR
Shanghai Institute of Planned Parenthood Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
sippr
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.